These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6681450)

  • 1. [Fibrinogen in diseases of the liver and its effect on the development of hemorrhage].
    Pastrakuljić N
    Srp Arh Celok Lek; 1983; 111(9-10):1317-23. PubMed ID: 6681450
    [No Abstract]   [Full Text] [Related]  

  • 2. Anemia--the overlooked factor in bleeding related to liver disease.
    Thachil J
    J Hepatol; 2011 Mar; 54(3):593-4; author reply 594-5. PubMed ID: 21087803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coagulation failure: diagnosis, management and therapeutic consequences].
    Ostermann H
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2482-4. PubMed ID: 17066361
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical value of determining fibrinogen level in liver diseases].
    Boiadzhiian KhP
    Klin Med (Mosk); 1985 Aug; 63(8):101-4. PubMed ID: 4079306
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No, but they need a careful look.
    Matsushita T; Saito H
    J Thromb Haemost; 2006 Sep; 4(9):2066-7. PubMed ID: 16796712
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool.
    Nilsson IM
    Scand J Haematol Suppl; 1971; 13():317-22. PubMed ID: 4945833
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with determination of fibrinogen degradation products.
    Hedner U; Nilsson M
    Acta Med Scand; 1971 Jun; 189(6):471-7. PubMed ID: 5000339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Abnormal fibrinogens in liver disorders].
    Hule V
    Vnitr Lek; 1976 Feb; 22(2):131-4. PubMed ID: 1258400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Micromethod for the quantitative determination of fibrinogen].
    Boiadzhiian Kh; Bakalova R
    Lab Delo; 1982; (5):265-7. PubMed ID: 6178877
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cystic liver with acute hemorrhage].
    Zoller WG; Kremer H; Mietaschk A; Eibl-Eibesfeldt B
    Dtsch Med Wochenschr; 1985 Jul; 110(30):1185-6. PubMed ID: 4017886
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).
    Kositchaiwat C; Chuansumrit A
    Thromb Haemost; 2001 Oct; 86(4):1125-6. PubMed ID: 11686340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complications of polycystic disease of the liver: apropos of 2 cases of intra-cystic hemorrhage].
    Quandalle P; Lasou F; Desurmont P; Chambon JP
    LARC Med; 1982 May; 2(5):399-400, 403-5. PubMed ID: 7167016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolysis in idiopathic renal hemorrhage].
    Ochiai K; Yokokawa M
    Kokubyo Gakkai Zasshi; 1967 Jun; 34(2):203-6. PubMed ID: 5235632
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.
    Fries D; Innerhofer P; Reif C; Streif W; Klingler A; Schobersberger W; Velik-Salchner C; Friesenecker B
    Anesth Analg; 2006 Feb; 102(2):347-51. PubMed ID: 16428520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen and blood protein fractions in acute and chronic liver diseases].
    BEVACQUA V; VILLA AM
    Prog Med (Napoli); 1957 Aug; 13(16):494-502. PubMed ID: 13485202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in platelet function in liver diseases].
    Castillo R; Casals FJ; Maragall S; Rodés J; Ordinas A
    Sangre (Barc); 1982; 27(4-B):672-9. PubMed ID: 7157140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of hematic fibrinogen in leukemias with hyperfibrinolysis].
    Girolami A
    Policlinico Med; 1966 Aug; 73(4):239-45. PubMed ID: 5989772
    [No Abstract]   [Full Text] [Related]  

  • 18. Approach to the bleeding patient.
    Marengo-Rowe AJ
    Int Anesthesiol Clin; 1982; 20(4):137-56. PubMed ID: 6816739
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic brucellosis of hemorrhagic form].
    Bataller Sifre R; Lombart Bosch A; Peiro Olaso V; Illueca Ferrer E
    Rev Esp Enferm Apar Dig; 1972 Apr; 37(2):219-28. PubMed ID: 5025242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemorrhage caused by fibrinogen deficiency in the course of an operation].
    Sadliński C; Podwiński A
    Przegl Lek; 1970; 26(6):561-2. PubMed ID: 5448392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.